Validation assays confirm the capacity of Atr-DEF2(G39-C54) to perturb the outer membrane, reduce aqueous Fe3+, and chelate Fe2+ supporting the hypothesis that Atr-DEF2 is membrane lytic and initiates iron deficiency. This evidence concerns the gene ATR and Iron deficiency anemia.